Skip to Content

WPI 3496 (Galantamine hydrobromide extended release 8 mg)

Pill imprint WPI 3496 has been identified as Galantamine hydrobromide extended release 8 mg.

Galantamine is used in the treatment of alzheimer's disease and belongs to the drug class cholinesterase inhibitors. Risk cannot be ruled out during pregnancy. Galantamine 8 mg is not a controlled substance under the Controlled Substance Act (CSA).

Galantamine hydrobromide extended release 8 mg WPI 3496
Galantamine hydrobromide extended release 8 mg WPI 3496
Discount Card Promo
Galantamine hydrobromide extended release
Imprint:
WPI 3496
Strength:
8 mg
Color:
White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3496
Inactive Ingredients:
gelatin
hydroxypropyl cellulose
magnesium stearate
silicon dioxide
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide